These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 30546312)
21. Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials. Okuyama Y; Oya K; Matsunaga S; Kishi T; Iwata N Neuropsychiatr Dis Treat; 2016; 12():3221-3236. PubMed ID: 28008259 [TBL] [Abstract][Full Text] [Related]
22. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis. Björkhem-Bergman L; Asplund AB; Lindh JD J Psychopharmacol; 2011 Mar; 25(3):299-305. PubMed ID: 20080925 [TBL] [Abstract][Full Text] [Related]
24. Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials. Zheng W; Li XB; Tang YL; Xiang YQ; Wang CY; de Leon J J Clin Psychopharmacol; 2015 Oct; 35(5):499-509. PubMed ID: 26280837 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of adjunctive treatments added to olanzapine or clozapine for weight control in patients with schizophrenia: a systematic review and meta-analysis. Choi YJ ScientificWorldJournal; 2015; 2015():970730. PubMed ID: 25664341 [TBL] [Abstract][Full Text] [Related]
26. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study. Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171 [TBL] [Abstract][Full Text] [Related]
27. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial. Anagnostou E; Aman MG; Handen BL; Sanders KB; Shui A; Hollway JA; Brian J; Arnold LE; Capano L; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Hadjiyannakis S; Peleg N; Odrobina D; McAuliffe-Bellin S; Zakroysky P; Marler S; Wagner A; Wong T; Macklin EA; Veenstra-VanderWeele J JAMA Psychiatry; 2016 Sep; 73(9):928-37. PubMed ID: 27556593 [TBL] [Abstract][Full Text] [Related]
28. A network meta-analysis for efficacy and safety of seven regimens in the treatment of type II diabetes. Wang LG; Wang H; Liu Q; Hua WC; Li CM Biomed Pharmacother; 2017 Aug; 92():707-719. PubMed ID: 28586742 [TBL] [Abstract][Full Text] [Related]
29. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials. Correll CU; Maayan L; Kane J; Hert MD; Cohen D J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425 [TBL] [Abstract][Full Text] [Related]
30. Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis. Siskind DJ; Leung J; Russell AW; Wysoczanski D; Kisely S PLoS One; 2016; 11(6):e0156208. PubMed ID: 27304831 [TBL] [Abstract][Full Text] [Related]
31. Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers. Fiedorowicz JG; Miller DD; Bishop JR; Calarge CA; Ellingrod VL; Haynes WG Curr Psychiatry Rev; 2012 Feb; 8(1):25-36. PubMed ID: 22712004 [TBL] [Abstract][Full Text] [Related]
32. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol. Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010 [TBL] [Abstract][Full Text] [Related]
33. Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Werneke U; Taylor D; Sanders TA Int Clin Psychopharmacol; 2002 Jul; 17(4):145-60. PubMed ID: 12131598 [TBL] [Abstract][Full Text] [Related]
34. Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophrenia. Biedermann F; Fleischhacker WW; Kemmler G; Ebenbichler CF; Lechleitner M; Hofer A Int Clin Psychopharmacol; 2014 May; 29(3):181-4. PubMed ID: 24300751 [TBL] [Abstract][Full Text] [Related]
35. [Metabolic side effects of risperidone in early onset schizophrenia]. Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267 [TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis. Zhang JP; Lencz T; Zhang RX; Nitta M; Maayan L; John M; Robinson DG; Fleischhacker WW; Kahn RS; Ophoff RA; Kane JM; Malhotra AK; Correll CU Schizophr Bull; 2016 Nov; 42(6):1418-1437. PubMed ID: 27217270 [TBL] [Abstract][Full Text] [Related]
37. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Misso ML; Costello MF; Garrubba M; Wong J; Hart R; Rombauts L; Melder AM; Norman RJ; Teede HJ Hum Reprod Update; 2013; 19(1):2-11. PubMed ID: 22956412 [TBL] [Abstract][Full Text] [Related]
38. Meta-analysis: pharmacologic treatment of obesity. Li Z; Maglione M; Tu W; Mojica W; Arterburn D; Shugarman LR; Hilton L; Suttorp M; Solomon V; Shekelle PG; Morton SC Ann Intern Med; 2005 Apr; 142(7):532-46. PubMed ID: 15809465 [TBL] [Abstract][Full Text] [Related]
39. Management of atypical antipsychotic drug-induced weight gain: focus on metformin. Miller LJ Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423 [TBL] [Abstract][Full Text] [Related]